Kleine Holthaus, S-M;
Smith, AJ;
Mole, SE;
Ali, RR;
(2018)
Gene Therapy Approaches to Treat the Neurodegeneration and Visual Failure in Neuronal Ceroid Lipofuscinoses.
In:
Retinal Degenerative Diseases.
(pp. pp. 91-99).
Springer: Cham, Switzerland.
![[thumbnail of Smith_kleine Holthaus et al.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Smith_kleine Holthaus et al.pdf - Accepted Version Access restricted to UCL open access staff Download (115kB) |
Abstract
Neuronal ceroid lipofuscinoses (NCLs) are a group of fatal, inherited lysosomal storage disorders mostly affecting the central nervous system of children. Symptoms include vision loss, seizures, motor deterioration and cognitive decline ultimately resulting in premature death. Studies in animal models showed that the diseases are amenable to gene supplementation therapies, and over the last decade, major advances have been made in the (pre)clinical development of these therapies. This mini-review summarises and discusses current gene therapy approaches for NCL targeting the brain and the eye.
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
